The pioneering cell, gene and regenerative medicines activity of UCL’s three NIHR Biomedical Research Centres (BRCs) UCLH, GOSH and Moorfields was showcased on 15th March, 2018 at a BRC showcase event organised by MedCity with input from the UCL CGRM TIN. UCL were represented in the plenary session panel discussion by Professors Emma Morris and Bobby Gaspar discussing routes to translation and commercialisation of academic products.
UCL’s exhibits highlighted:
• UCLH BRC’s groundbreaking CAR-T cell programme, innovative work in foetal gene and stem cell therapies and tissue engineering spinout Engitix
• GOSH BRC’s world-leading work in gene-modified cell therapy for primary immune deficiencies
• MEH BRC’s novel cell therapies for retinal and corneal disease